Research Topics
Species | M WirthSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trialMaximilian Burger
Department of Urology, Caritas St, Josef Medical Centre, University of Regensburg, Regensburg, Germany
J Transl Med 8:54. 2010..The present trial compared autologous intravesical macrophage cell therapy (BEXIDEM) to BCG in patients after transurethral resection (TURB) of BC...
[Prostate cancer. Current and practice-relevant news from urology in 2011]M Wirth
Universitatsklinikum Dresden, Fetscherstrasse 74, Dresden, Germany
Urologe A 50:173-5. 2011..For metastasized prostate cancer new immunotherapeutic, chemotherapeutic and hormonal options are now available or will soon be approved...
[The significance of comorbidity and age in radical prostatectomy]M Wirth
Klinik und Poliklinik fur Urologie, Universitätsklinikum Carl Gustav Carus der technischen Universität Dresden
Urologe A 43:935-41. 2004....
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 yearsManfred P Wirth
Department of Urology, Technical University of Dresden, Dresden, Germany
J Urol 172:1865-70. 2004..We evaluated the efficacy and tolerability of 150 mg bicalutamide daily given in addition to standard care, in patients with localized or locally advanced prostate cancer...
Optimal treatment of locally advanced prostate cancerManfred P Wirth
Department of Urology, University Hospital, Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
World J Urol 25:169-76. 2007..Adjuvant hormonal treatment may improve outcome in this setting. When no curative treatment is chosen, early hormonal treatment seems to provide modest benefit compared with deferred therapy...
Lymph node disease after radical prostatectomyM P Wirth
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Minerva Urol Nefrol 59:53-7. 2007..Overall, there is a need to enroll patients with lymph node involvement at radical prostatectomy onto clinical studies to improve the body of knowledge on optimal management in these cases...
Hormone-refractory prostate cancer: what have we learned?Manfred P Wirth
Department of Urology, Technical University Dresden, Dresden, Germany
BJU Int 100:56-9. 2007
Antiandrogens in the treatment of prostate cancerManfred P Wirth
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
Eur Urol 51:306-13; discussion 314. 2007..To give an overview on the contemporary role of antiandrogens in prostate cancer treatment...
Adjuvant hormonal treatment - the bicalutamide early prostate cancer programManfred P Wirth
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Front Radiat Ther Oncol 41:39-48. 2008..Altogether, there is no indication for treatment with bicalutamide in patients with localized disease...
[Treatment of locally advanced prostate cancer]M P Wirth
Klinik und Poliklinik fur Urologie, Universitatsklinikum Carl Gustav Carus, Technische Universitat, Dresden
Urologe A 44:1295-302. 2005..If in case of severe comorbidity or advanced age primary hormonal treatment is chosen, early vs deferred treatment seems to prolong survival marginally...
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-upM Wirth
Department of Urology, Technical University of Dresden, Dresden, Germany
Prostate Cancer Prostatic Dis 10:87-93. 2007..66; 95% confidence interval 0.55, 0.79; P<0.001). In localized disease, a significant difference in objective PFS was not found. There was no significant difference in overall survival...
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progressionM Wirth
Department of Urology, Technical University of Dresden, Dresden, Germany
Urology 58:146-51. 2001..Longer follow-up is underway to assess any benefit in overall survival...
[Value of lymphadenectomy for limited nodal recurrence of prostate cancer after local therapy with curative intent]I Wolff
Klinik und Poliklinik fur Urologie, Universitatsklinikum Carl Gustav Carus, Technische Universitat Dresden, Fetscherstr 74, 01307, Dresden, Deutschland
Urologe A 47:1436-40. 2008..The available data on oncological outcomes of this procedure are insufficient. Therefore, lymphadenectomy for nodal recurrence of prostate cancer remains an unproven approach...
Adjuvant hormonal treatment for prostate cancer: the bicalutamide early prostate cancer programManfred P Wirth
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Oncology 65:1-4. 2003..58, 95% confidence interval 0.51-0.66, p < 0.0001). However, further maturation of data is needed to see whether this difference will lead to a survival advantage...
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth
Technical University of Dresden Medical School, Dresden, Germany
Prostate Cancer Prostatic Dis 8:194-200. 2005..746). In the context of the whole EPC programme, long-term bicalutamide is not appropriate for localised disease, yet provides advantages in delaying disease progression in patients with locally advanced prostate cancer...
Delaying/reducing the risk of clinical tumour progression after primary curative proceduresM Wirth
Department of Urology, Technical University of Dresden, Germany
Eur Urol 40:17-23. 2001..The programme is ongoing, and survival data are awaited...
[Pelvic lymphadenectomy and radical prostatectomy. Recommendations of the German S3 guideline]M O Grimm
Klinik und Poliklinik fur Urologie, Universitatsklinikum Carl Gustav Carus, Technische Universitat Dresden, Fetscherstrasse 74, 01307 Dresden
Urologe A 49:206-10. 2010..Radical prostatectomy has to be performed under the supervision of an experienced surgeon. This includes the number of 50 prostatectomies per year and institution, 25 prostatectomies per surgeon, and an appropriate training program...
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle
Institute of Immunology, Medical Faculty, Technical University Dresden, Dresden, Germany
Int J Cancer 109:882-92. 2004..These results validate D-PCa-2 as a transcript with high tissue specificity and with a potential application in the diagnosis of PCa...
Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignanciesUta Schmidt
Department of Urology, Technical University of Dresden, Fetscherstr 74, D 01307 Dresden, Germany
Cancer Lett 225:253-60. 2005..5-fold upregulation was observed in samples from 17 patients (28%). In contrast, C13orf19 mRNA alterations in expression seemed to be random events in kidney cancers...
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growthShuangli Ning
Department of Urology, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany
Int J Oncol 25:1065-71. 2004..In summary, the results suggest that the anti-survivin siRNA treatment might represent a suitable therapeutic approach to selectively inhibit growth of BCa cells in addition to commonly applied therapy schemes...
[Molecular genetic markers for prostate cancer. Evidence in fine needle biopsies for improved confirmation of the diagnosis]S Schneider
Klinik für Urologie, Technische Universitat, Dresden, Deutschland
Urologe A 47:1208-11. 2008..Furthermore, an extension of this approach to PCa prognosis and the transfer to urine samples appear very promising...
Value of endocrine therapy for early and locally advanced prostate cancerManfred P Wirth
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Germany
Drugs Aging 20:115-24. 2003..Several large studies are under way to investigate the role of adjuvant treatment in the field of early prostate cancer...
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause
Institutes of Biochemistry, Technical University Dresden, Dresden, Germany
J Urol 174:328-31. 2005..We suggest VEGF as an additional putative target to enhance the therapeutic benefit of, for example mitomycin C and gemcitabine instillation treatment schedules...
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cellsKai Kraemer
Department of Urology, Technical University Dresden, D-01307, Dresden, Germany
Clin Cancer Res 9:3794-800. 2003..We propose that this alternative treatment could be applied in terms of an instillation therapy...
Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomyMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urology 62:698-701. 2003..CONCLUSIONS: In experienced hands, the ASA classification is a promising tool to improve the classification of prognostic comorbidity in the radical prostatectomy setting and may be used as an alternative to the Charlson score...
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancerManfred P Wirth
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
Eur Urol 45:267-70; discussion 270. 2004..To assess the efficacy and the tolerability of flutamide as adjuvant treatment after radical prostatectomy for locally advanced, lymph node-negative prostate cancer...
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle
Institute of Immunology, Medical Faculty, Technical University of Dresden, Germany
Biochem Biophys Res Commun 322:239-49. 2004..These data provide the basis for future studies evaluating the diagnostic potential of D-GPCR and its utility as a novel target in immunotherapy of prostate cancer...
Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCRSusanne Fuessel
Department of Urology, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany
Int J Oncol 23:221-8. 2003..According to our data, the novel marker trp-p8 seems to represent a highly prostate-specific and PCa-associated gene qualifying it as a potential target for specific therapies...
Quantitative multi-gene expression profiling of primary prostate cancerUta Schmidt
Department of Urology, Technical University of Dresden, Germany
Prostate 66:1521-34. 2006....
Perspectives in adjuvant treatment of prostate cancerManfred P Wirth
Department of Urology, University Clinics Carl Gustav Carus, Technical University of Dresden, Germany. wirth-msrcs.urz.tu-dresdan.de
Urol Int 68:1-5. 2002
The role of toll-like receptors in the immune-adrenal crosstalkS R Bornstein
Department of Anesthesiology, Heinrich Heine University, Dusseldorf, Germany
Ann N Y Acad Sci 1088:307-18. 2006..In conclusion, TLRs play a crucial role in the immune-adrenal crosstalk. This close functional relationship needs to be considered in the treatment of inflammatory diseases requiring an intact adrenal stress response...
Molecular therapy in urologic oncologyMichael Froehner
Department of Urology, University Hospital, Technical University of Dresden, Dresden, Germany
Urol Int 79:1-7. 2007..The great theoretical potential and the multitude of possible targets and drug combinations, however, support further research into this exciting field of medical treatment of urologic malignancies...
Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of ageMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urology 68:583-6. 2006....
Treatment of locally advanced prostate cancer--the case for radical prostatectomyOliver W Hakenberg
Klinik und Poliklinik fur Urologie, Universitätsklinikum Carl Gustav Carus der technischen Universität Dresden, Dresden, Germany
Urol Int 77:193-9. 2006..If, in case of advanced age and/or significant comorbidity, primary hormonal treatment is chosen, early hormonal deprivation therapy seems to offer marginal benefits in survival compared to delayed treatment...
Cisplatin, methotrexate and bleomycin for treating advanced penile carcinomaOliver W Hakenberg
Department of Urology, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany
BJU Int 98:1225-7. 2006....
Magnetic resonance imaging of bone metastases in patients with nonseminomatous germ cell tumorsMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urol Oncol 25:201-6. 2007..To investigate the role of magnetic resonance imaging (MRI) of bone metastases in nonseminomatous germ cell tumors...
Changing comorbidity classification patterns at radical prostatectomy during a 10-year periodMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urol Oncol 25:26-31. 2007..To investigate the consistency of several comorbidity classifications and concomitant diseases at radical prostatectomy (RP) during a 10-year period...
Successful chemotherapy for advanced nonseminomatous germ-cell tumor in a patient undergoing chronic hemodialysisMichael Froehner
Department of Urology, University Hospital, Technical University of Dresden, Dresden, Germany
J Clin Oncol 25:1282-4. 2007
Interaction between age and comorbidity as predictors of mortality after radical prostatectomyMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
J Urol 179:1823-9; discussion 1829. 2008..We identified an age range in which comorbidity is most closely associated with premature mortality after radical prostatectomy...
Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinomaMarieta I Toma
Institute of Pathology, Medicine University Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Cancer Invest 29:123-9. 2011..05). The overall survival and the disease-specific survival correlated negatively with the Ki67 status (p < .05). FOXP1 expression negatively correlated with Ki67 expression in clear cell renal cell carcinomas (p = .036)...
Anticholinergic effects of cis- and trans-isomers of two metabolites of propiverineStefan Propping
Department of Urology, University Hospital Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, 01307 Dresden, Germany
Naunyn Schmiedebergs Arch Pharmacol 381:329-38. 2010..However, at higher concentration ranges, all four compounds seem to have additional effects on Ca(2+) influx...
Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controlsSven Oehlschläger
Department of Urology, Technical University, Dresden, Germany
Urology 77:250.e1-5. 2011....
Second cancers as competing causes of death after radical prostatectomyMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
J Urol 182:967-70. 2009..We analyzed the risk of dying of a second cancer after radical prostatectomy for clinically localized prostate cancer...
Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patientDaniela Wuttig
Department of Urology, Dresden University of Technology, Dresden, Germany
Int J Cancer 125:474-82. 2009..To what extent the identified molecular factors contribute to the development of these characteristics of metastatic spread needs to be analyzed in further studies...
Derivatives of prostate-specific antigen as predictors of incidental prostate cancerMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
BJU Int 104:25-8. 2009..5-10 ng/ml...
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysisStefan Zastrow
Department of Urology, University Hospital Carl Gustav Carus, Dresden, Germany
Urology 73:868-70. 2009..To report on 2 cases of metastatic renal cell cancer treated with sunitinib during chronic hemodialysis...
Differential expression and action of Toll-like receptors in human adrenocortical cellsWaldemar Kanczkowski
Department of Medicine, Carl Gustav Carus University Hospital, Technical University of Dresden, 01307 Dresden, Germany
Mol Cell Endocrinol 300:57-65. 2009..Therefore, Toll-like receptors expression and function is a novel feature of the adrenal stress system contributing to adrenal tissue homeostasis, regeneration and tumorigenesis...
Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cellsDoreen Kunze
Department of Urology, Technical University of Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
Anticancer Res 28:2259-63. 2008..The knockdown of XIAP, BCL2 and BCL-X(L) by siRNAs represents a promising treatment option for bladder cancer (BCa) since the overexpression of antiapoptotic genes is often associated with tumor progression and treatment resistance...
Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomyMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urology 72:1252-7. 2008..To investigate the prognostic significance of the individual conditions contributing to the Charlson comorbidity score in patients selected for radical prostatectomy...
Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping arrayMarieta I Toma
Institute for Pathology, University of Technology Dresden, D 01307 Dresden, Germany
Neoplasia 10:634-42. 2008..Genome-wide SNP array analysis not only confirmed previously described large chromosomal aberrations but also detected novel microdeletions in genes potentially involved in tumor genesis of cc-RCC...
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivoDoreen Kunze
Department of Urology, Faculty of Medicine, Technical University of Dresden, 01307 Dresden, Germany
Int J Oncol 32:1049-56. 2008..In vivo studies with 9 consecutive intraperitoneal injections with 20 mg/kg AS-ODNs or 4.6 mg/kg siRNAs revealed the biocompatibility of both antisense inhibitor types and showed anti-tumoural activity of the AS-ODNs used...
Multifocal recurring epithelioid hemangioendothelioma of the penisStefan Zastrow
Department of Urology, University Hospital Carl Gustav Carus, Dresden, Germany
Urology 71:351.e9-10. 2008..We present a case of epithelioid hemangioendothelioma of the penis in a 57-year-old man, and its treatment. Differential diagnoses and treatment of this rare disease are discussed...
11C-acetate positron emission tomography for occult prostate cancerMichael Froehner
Department of Urology, University Hospital, Technical University of Dresden, Dresden, Germany
Urol Oncol 24:410-1. 2006..We report, to our knowledge previously not described, a case of occult prostate cancer, in which 11C-acetate positron emission tomography disclosed tumor manifestation after failure of conventional diagnostic procedures...
Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancerMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urol Int 76:27-30. 2006..To compare the clinical value of the measurement of complex and total PSA in the discrimination between benign prostatic hyperplasia (BPH) and prostate cancer...
Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomyMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Scand J Urol Nephrol 39:449-54. 2005..To identify and compare tumor- and non-tumor-related predictors of survival after radical prostatectomy and to incorporate the latter into the tumor node metastasis classification of prostate cancer...
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumorsPanagiotis Tsatalpas
Department of Urology, University of Dresden, Germany
Urol Int 68:157-63. 2002..Possible advantages compared to CT, however, are as yet not clearly defined. The possibility of false-positive PET findings due to reactive supradiaphragmatic inflammatory processes early after chemotherapy have to be considered...
Significance of testicular microlithiasisStefan Zastrow
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urol Int 75:3-7. 2005..Testicular microlithiasis is an uncommon condition characterized by calcifications within the seminiferous tubules. The true prevalence in a normal population has not been defined...
Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairsSusanne Fuessel
Department of Urology, Technical University Dresden, Fetscherstr 74, D 01307 Dresden, Germany
Cancer Lett 236:95-104. 2006..6452. Hence, the evaluation of D-GPCR as possible additive diagnostic tool and putative therapy target appears promising...
Renal staghorn calculus?Michael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urology 65:171. 2005
Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomyMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
Eur Urol 47:190-5; discussion 195. 2005..To compare different comorbidity classifications as predictors of survival after radical prostatectomy (RPE)...
Urinary immunocytology for primary bladder B cell lymphomaMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urology 63:381-3. 2004..Lymphoma cells were distinguished from abundant leukocytes by immunocytologic staining for CD20. This technique might be useful in the differential diagnosis of patients with chronic bladder inflammation accompanied by pyuria...
Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomyMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urology 61:596-600. 2003....
Distal ureteral stenosis after early adjuvant intravesical mitomycin C application for superficial bladder cancerSven Oehlschläger
Department of Urology, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
Urol Int 70:74-6. 2003..Although ureteral stenosis does occur after transurethral resection, the severity and time course of the stenosis in this case suggest an influence of the intravesical chemoprophylaxis used...
Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumorMichael Froehner
Department of Urology, University Hospital, Technical University of Dresden, Fetscherstrasse 74, 01307, Dresden, Germany
Cancer Chemother Pharmacol 58:716-8. 2006..We report on the--to our knowledge--first treatment experiment with imatinib in a patient with metastatic Leydig cell tumor. Unfortunately, the tumor progressed during treatment...
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNASusanne Fuessel
Department of Urology, Technical University Dresden, Fetscherstr 74, D 01307 Dresden, Germany
Cancer Lett 232:243-54. 2006..Nevertheless, both therapy approaches in combination with all tested chemotherapeutics provoked a remarkable inhibition of viability and may serve as suitable additive tools for chemosensitization of bladder cancer cells...
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trialSusanne Fuessel
Department of Urology, Medical Faculty, Technical University Dresden, Dresden, Germany
Prostate 66:811-21. 2006..The application of a peptide cocktail-derived from different antigens as a novel treatment modality is supposed to allow for the genetic and biologic heterogeneity of PCa...
Perioperative complications of radical cystectomy in a contemporary seriesVladimir Novotny
Department of Urology, Technical University, Dresden, Germany
Eur Urol 51:397-401; discussion 401-2. 2007..We retrospectively evaluated our series of patients who underwent radical cystectomy for advanced bladder cancer for perioperative complications as well as operative time, postoperative hospital stay and transfusion rates...
Nomogram underestimates 10-year survival in healthy men selected for radical prostatectomy at age 70 years or olderMichael Froehner
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
Urology 73:610-3; discussion 613-4. 2009..To externally review a nomogram developed to predict the 10-year survival probability of men selected for radical prostatectomy...
New approaches in the modulation of bladder smooth muscle cells on viable detrusor constructsGouya Ram-Liebig
Department of Urology, Technical University of Dresden, Fetscherstrasse 74, 01307, Dresden, Germany
World J Urol 24:429-37. 2006..SMC-phenotype can be modulated in viable detrusor constructs by applying selected combinations of urothelial-conditioned media and mechanical stimulation under stepwise reduction and elimination of serum...
Impact of resection margin status after nephron-sparing surgery for renal cell carcinomaNavid Berdjis
Department of Urology, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany
BJU Int 97:1208-10. 2006..1 cm in patients with progression and 3.1 cm in patients who remained recurrence-free. CONCLUSIONS: Our data suggest that the width of the resection margin, unlike tumour size, does not influence the risk of tumour recurrence...
Functional analyses of C13orf19/P38IP in prostate cell linesDoreen Kunze
Department of Urology, Technical University Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
Oncol Rep 15:1599-604. 2006..No interaction between C13orf19 and p38MAPK was identified. Therefore, the gene should forthwith be named C13orf19 or Fam48A and not P38IP...
Synthetic nucleic acids as potential therapeutic tools for treatment of bladder carcinomaSusanne Fuessel
Department of Urology, Technical University of Dresden, Dresden, Germany
Eur Urol 51:315-26; discussion 326-7. 2007..Therefore, silencing of abnormally activated genes appears to be a rational approach for specific target-directed and sensitising therapies...
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8Andrea Kiessling
Institute of Immunology, Medical Faculty, Technical University of Dresden, Dresden, Germany
Prostate 56:270-9. 2003..Here, we identify for the first time an immunogenic peptide derived from the prostate-specific protein transient receptor potential-p8 (trp-p8) that is recognized by cytotoxic T lymphocytes (CTLs) from PCa patients...
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contractionMelinda Wuest
Institute of Pharmacology and Toxicology, Dresden University of Technology, Fetscherstrasse 74, D 01307 Dresden, Germany
Br J Pharmacol 145:608-19. 2005..5. The investigated responses to propiverine and its metabolites suggest that impairment of maximum CCh-induced contractions is due to strong effect on I(Ca) and that this may be associated with the presence of the aliphatic side chain...
Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouseMelinda Wuest
Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany
Eur J Pharmacol 565:180-9. 2007....
Systematic development of a guideline for early detection of prostate cancer: the German way in the evidence gapH J Luboldt
Department of Urology, University of Duisburg Essen, Hufelandstr 55, Essen, Germany
Eur Urol 46:725-30. 2004..To develop an evidence-based guideline, helping physcians make prudent decisions about diagnostic care for men wishing to undergo examination for early detection of prostate cancer...
[Acute abdominal pain due to a ventriculo-peritoneal shunt metastasis of an intracranial germ cell tumor]S Schrodter
Klinik und Poliklinik fur Urologie, Universitätsklinikum Carl Gustav Carus der technischen Universität Dresden, Fetscherstrasse 74, 01307 Dresden
Aktuelle Urol 37:141-2. 2006..Extracranial metastases of pineal germinomas are rare...
Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center studyKaren Blümke
Clinic of Urology, University Halle Wittenberg, Ernst Grube Str 4, D 06120 Halle Saale, Germany
Oncol Rep 14:895-9. 2005..The occurrence and the quantity of CTC in RCC patients is an early disease event. Furthermore, the occurrence of CTC is correlated with an advanced tumor stage and seems to be associated with a more aggressive tumor phenotype...
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer programWilliam A See
Medical College of Wisconsin, Milwaukee, Wisconsin, USA
J Urol 168:429-35. 2002..This benefit must be balanced with the morbidity associated with long-term hormonal therapy. Followup is ongoing to determine potential survival benefits of this treatment approach...
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer programPeter Iversen
Department of Urology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark
Urology 63:928-33. 2004....
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapyUta Schmidt
Technical University of Dresden, Department of Urology, D 01307 Dresden, Germany
Int J Oncol 24:1393-9. 2004..This study demonstrates that circulating tumor cells are detectable during chemotherapy for hormone-refractory prostate cancer regardless of the degree of PSA response...
Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatmentKai Kraemer
Department of Urology, Technical University Dresden, Dresden, Germany
J Urol 172:2023-8. 2004..CONCLUSIONS: Enhancement of cytotoxic drug effects on the growth of TCC cells by hTERT AS-ODNs presented herein allows a dose decrease in chemotherapy and confirms the suitability of hTERT as a target in a specific therapy approach...
Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFRKai Kraemer
Department of Urology, Technical University of Dresden, Dresden, Germany
Int J Cancer 119:1276-84. 2006..The detailed clarification of these processes will shed light on the question, whether telomerase inhibitors might constitute suitable anticancer tools...
The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal usePierre Teillac
Hopital St Louis, Paris, France
Clin Ther 27:273-85. 2005..Investigators continue to explore the use of hormone therapy, particularly luteinizing hormone-releasing hormone (LHRH) analogues, earlier in the course of disease...
Treating renal cell cancer in the elderlyNavid Berdjis
Department of Urology, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01309 Dresden, Germany
BJU Int 97:703-5. 2006..Advanced age alone should thus not be used as a criterion to deny surgery for renal cell carcinoma. However, older patients should be counselled regarding a tendency for increased comorbidity-related peri-operative mortality...
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancerDavid G McLeod
Walter Reed Army Medical Center, Washington, DC, USA
BJU Int 97:247-54. 2006..To evaluate, in the ongoing Early Prostate Cancer (EPC) trial programme, the efficacy and tolerability of bicalutamide 150 mg once daily in addition to standard care for localized or locally advanced, nonmetastatic prostate cancer...
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer ProgrammeChris J Tyrrell
Derriford Hospital, Plymouth, UK
Radiother Oncol 76:4-10. 2005....
